➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
McKinsey
Baxter
Mallinckrodt
Boehringer Ingelheim

Last Updated: January 27, 2021

DrugPatentWatch Database Preview

Actavis Mid Atlantic Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACTAVIS MID ATLANTIC, and what generic and branded alternatives to ACTAVIS MID ATLANTIC drugs are available?

ACTAVIS MID ATLANTIC has sixty-two approved drugs.



Summary for Actavis Mid Atlantic

Drugs and US Patents for Actavis Mid Atlantic

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic NYSTATIN nystatin OINTMENT;TOPICAL 062840-001 Nov 13, 1987 AT RX No No   Start Trial   Start Trial
Actavis Mid Atlantic CLEMASTINE FUMARATE clemastine fumarate SYRUP;ORAL 074075-001 Oct 31, 1993 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic CAPITAL AND CODEINE acetaminophen; codeine phosphate SUSPENSION;ORAL 085883-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic ALBUTEROL SULFATE albuterol sulfate SOLUTION;INHALATION 073533-001 Sep 26, 1995 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride SYRUP;ORAL 090378-002 May 9, 2008 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic VALNAC betamethasone valerate CREAM;TOPICAL 070050-001 Oct 10, 1984 AB RX No No   Start Trial   Start Trial
Actavis Mid Atlantic LIDOCAINE HYDROCHLORIDE VISCOUS lidocaine hydrochloride SOLUTION;ORAL 086578-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Johnson and Johnson
McKesson
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.